Estradiol Patch, Extended Release
Product Images NDC 69238-1632

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 69238-1632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Estradiol Transdermal System Usp Vivelle 1)

FDA Label Image

Instructions 4a (Estradiol Transdermal System Usp Vivelle 10)

FDA Label Image

Instructions 4b (Estradiol Transdermal System Usp Vivelle 11)

FDA Label Image

Instructions 4c (Estradiol Transdermal System Usp Vivelle 12)

FDA Label Image

Instructions 4d (Estradiol Transdermal System Usp Vivelle 13)

FDA Label Image

Instructions 4e (Estradiol Transdermal System Usp Vivelle 14)

FDA Label Image

Instructions 4f (Estradiol Transdermal System Usp Vivelle 15)

FDA Label Image

Instructions 4g (Estradiol Transdermal System Usp Vivelle 16)

FDA Label Image

0.025 mg/day Pouch (Estradiol Transdermal System Usp Vivelle 17)

This is a description of a medication containing 0.025 mg/day of Estradiol delivered through a Transdermal System. It is prescribed and each system contains 0.314 mg of estradiol along with inactive components such as adhesives, alcohol, and film. The package is not child-resistant and should not be kept within reach of children. The medication should be applied immediately upon removal and should not be stored unpouched. It can be stored between 20" to 25°C with permitted excursions. This medication is distributed by Amneal Pharmaceuticals LLC.*

FDA Label Image

0.025 mg/day Carton (Estradiol Transdermal System Usp Vivelle 18)

FDA Label Image

0.0375 mg/day Pouch (Estradiol Transdermal System Usp Vivelle 19)

This is a prescription-only Estradiol Transdermal System that delivers 0.0375 mg/day twice weekly. Each 2.83 cm² system contains 0.470 mg of estradiol, USP. It comes with inactive components like acrylc achesive, siicone adhesie, oleyl alcohol, povidone and dipropylene glycol. This transdermal system is not child-resistant, so it is important to keep it out of the reach of children, and apply it immediately upon removing it from the pouch. It should be stored at a temperature between 20 to 25°C (68°F to 77°F); excursions permitted between 15-30°C (59°F to 86°F) [USP Controlled Room Temperature]. This product has been distributed by Amneal Pharmaceuticals, LLC and the package has been revised in December 2021.*

FDA Label Image

Active Component System (Estradiol Transdermal System Usp Vivelle 2)

FDA Label Image

0.0375 mg/day Carton (Estradiol Transdermal System Usp Vivelle 20)

FDA Label Image

0.05 mg/day Pouch (Estradiol Transdermal System Usp Vivelle 21)

This text describes a medication product that comes in a 3.78 e system and contains 0.627 mg of estradiol. It includes details about its inactive components, storage instructions, and an important warning regarding its child-resistant packaging. The product is distributed by Amneal Pharmaceuticals LLC based in Bridgewater, NJ.*

FDA Label Image

0.05 mg/day Carton (Estradiol Transdermal System Usp Vivelle 22)

Not available.*

FDA Label Image

0.075 mg/day Pouch (Estradiol Transdermal System Usp Vivelle 23)

This is a description of a medication called "Estradiol Transdermal System, USP", which is a patch that delivers 0.075 mg of estradiol twice a week. The patch is a 5.66 cm² system that contains 0.940 mg of estradiol and is applied immediately upon removal from the pouch. The inactive components of the patch include acrylic adhesive, silicone adhesive, oleyl alcohol, povidone, and dipropylene glycol. The patch should be stored at 20°C to 25°C and kept out of the reach of children. It is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

FDA Label Image

0.075 mg/day Carton (Estradiol Transdermal System Usp Vivelle 24)

FDA Label Image

0.1 mg/day Pouch (Estradiol Transdermal System Usp Vivelle 25)

This is a product description for a 7.55 cm² system with 1.253 mg of estradiol, USP. The system includes acrylic adhesive, silicone adhesive, oleyl alcohol, povidone, and dipropylene glycol, with a polyester and ethylene vinyl acetate copolymer film, and a polyester release liner. This product is prescription-only and should be kept out of the reach of children. It should be applied immediately after removal from its pouch, and not stored unpouched. The product should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

FDA Label Image

0.1 mg/day Carton (Estradiol Transdermal System Usp Vivelle 26)

This is not-available. The text consists of seemingly random combinations of letters, numbers, and symbols, and it is not possible to generate a useful description from it.*

FDA Label Image

1 (Estradiol Transdermal System Usp Vivelle 3)

This appears to be a graph depicting concentration levels (measured in pg/mL) over time (measured in days) for different doses of an unknown substance. The x-axis shows the time in days and the y-axis shows the concentration in pg/mL. The graph has five data points representing the concentration for different doses ranging from 0.0375 mg/day to 0.1 mg/day. The graph appears to have a positive correlation, meaning that as the dose increases, the concentration also increases. There is not enough context to determine the purpose or nature of the substance being measured.*

FDA Label Image

Figure (Estradiol Transdermal System Usp Vivelle 4)

FDA Label Image

3 (Estradiol Transdermal System Usp Vivelle 5)

This is a data table showing the percentage change from baseline in response to different treatments over the course of weeks 2, 7, and 104. The treatments include different doses of Estradiol and a placebo.*

FDA Label Image

4 (Estradiol Transdermal System Usp Vivelle 6)

This appears to be a table showing the results of a study or experiment with different treatments and their duration. The treatments include Estradiol administered in varying doses and a placebo. The data presented shows the percentage change from baseline at different durations (Week 26, 52, 78, and 104). However, there is some unclear text mixed in with the table headers, such as "ABCVSP" and "BN lLoanmnwroo~". Without further context, it's difficult to determine what these mean.*

FDA Label Image

Instructions 1 (Estradiol Transdermal System Usp Vivelle 7)

This is a visual representation of the schedule and days for changing the Estradiol Transdermal System patch. It appears that the patch should be changed only on two specific days, as indicated by the vertical bars separating Sned/ThuiSun and TuefFr/savTue. The days of the week are also listed.*

FDA Label Image

Instructions 2 (Estradiol Transdermal System Usp Vivelle 8)

FDA Label Image

Instructions 3 (Estradiol Transdermal System Usp Vivelle 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.